Biological activities of 7-dehydrocholesterol-derived oxysterols: Implications for Smith-Lemli-Opitz syndrome

Z. Korade, Libin Xu, Richard Shelton, Ned A. Porter

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Smith-Lemli-Opitz syndrome (SLOS) is a metabolic and developmental disorder caused by mutations in the gene encoding the enzyme 7-dehydrocholesterol reductase (Dhcr7). This reductase catalyzes the last step in cholesterol biosynthesis, and levels of 7-dehydrocholesterol (7-DHC), the substrate for this enzyme, are elevated in SLOS patients as a result of this defect. Our group has previously shown that 7-DHC is extremely prone to free radical autoxidation, and we identified about a dozen different oxysterols formed from oxidation of 7-DHC. We report here that 7-DHC-derived oxysterols reduce cell viability in a dose-and time-dependent manner, some of the compounds showing activity at sub-micromolar concentrations. The reduction of cell survival is caused by a combination of reduced proliferation and induced differentiation of the Neuro2a cells. The complex 7-DHC oxysterol mixture added to control Neuro2a cells also triggers the gene expression changes that were previously identified in Dhcr7-deficient Neuro2a cells. Based on the identification of overlapping gene expression changes in Dhcr7-deficient and 7-DHC oxysterol-treated Neuro2a cells, we hypothesize that some of the pathophysiological findings in the mouse SLOS model and SLOS patients might be due to accumulated 7-DHC oxysterols.

Original languageEnglish
Pages (from-to)3259-3269
Number of pages11
JournalJournal of Lipid Research
Volume51
Issue number11
DOIs
Publication statusPublished - Nov 2010

Fingerprint

Smith-Lemli-Opitz Syndrome
Bioactivity
Gene expression
Cell Survival
Cells
Overlapping Genes
Gene Expression
Gene encoding
Biosynthesis
Enzymes
7-dehydrocholesterol
Oxysterols
Free Radicals
Cell Differentiation
Oxidoreductases
Cholesterol
Oxidation
Defects
Mutation

Keywords

  • Free radical oxidation
  • Gene expression
  • Lipid peroxidation

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Endocrinology

Cite this

Biological activities of 7-dehydrocholesterol-derived oxysterols : Implications for Smith-Lemli-Opitz syndrome. / Korade, Z.; Xu, Libin; Shelton, Richard; Porter, Ned A.

In: Journal of Lipid Research, Vol. 51, No. 11, 11.2010, p. 3259-3269.

Research output: Contribution to journalArticle

Korade, Z. ; Xu, Libin ; Shelton, Richard ; Porter, Ned A. / Biological activities of 7-dehydrocholesterol-derived oxysterols : Implications for Smith-Lemli-Opitz syndrome. In: Journal of Lipid Research. 2010 ; Vol. 51, No. 11. pp. 3259-3269.
@article{87e6fc708d1d4757b1744f114ff14005,
title = "Biological activities of 7-dehydrocholesterol-derived oxysterols: Implications for Smith-Lemli-Opitz syndrome",
abstract = "Smith-Lemli-Opitz syndrome (SLOS) is a metabolic and developmental disorder caused by mutations in the gene encoding the enzyme 7-dehydrocholesterol reductase (Dhcr7). This reductase catalyzes the last step in cholesterol biosynthesis, and levels of 7-dehydrocholesterol (7-DHC), the substrate for this enzyme, are elevated in SLOS patients as a result of this defect. Our group has previously shown that 7-DHC is extremely prone to free radical autoxidation, and we identified about a dozen different oxysterols formed from oxidation of 7-DHC. We report here that 7-DHC-derived oxysterols reduce cell viability in a dose-and time-dependent manner, some of the compounds showing activity at sub-micromolar concentrations. The reduction of cell survival is caused by a combination of reduced proliferation and induced differentiation of the Neuro2a cells. The complex 7-DHC oxysterol mixture added to control Neuro2a cells also triggers the gene expression changes that were previously identified in Dhcr7-deficient Neuro2a cells. Based on the identification of overlapping gene expression changes in Dhcr7-deficient and 7-DHC oxysterol-treated Neuro2a cells, we hypothesize that some of the pathophysiological findings in the mouse SLOS model and SLOS patients might be due to accumulated 7-DHC oxysterols.",
keywords = "Free radical oxidation, Gene expression, Lipid peroxidation",
author = "Z. Korade and Libin Xu and Richard Shelton and Porter, {Ned A.}",
year = "2010",
month = "11",
doi = "10.1194/jlr.M009365",
language = "English",
volume = "51",
pages = "3259--3269",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "11",

}

TY - JOUR

T1 - Biological activities of 7-dehydrocholesterol-derived oxysterols

T2 - Implications for Smith-Lemli-Opitz syndrome

AU - Korade, Z.

AU - Xu, Libin

AU - Shelton, Richard

AU - Porter, Ned A.

PY - 2010/11

Y1 - 2010/11

N2 - Smith-Lemli-Opitz syndrome (SLOS) is a metabolic and developmental disorder caused by mutations in the gene encoding the enzyme 7-dehydrocholesterol reductase (Dhcr7). This reductase catalyzes the last step in cholesterol biosynthesis, and levels of 7-dehydrocholesterol (7-DHC), the substrate for this enzyme, are elevated in SLOS patients as a result of this defect. Our group has previously shown that 7-DHC is extremely prone to free radical autoxidation, and we identified about a dozen different oxysterols formed from oxidation of 7-DHC. We report here that 7-DHC-derived oxysterols reduce cell viability in a dose-and time-dependent manner, some of the compounds showing activity at sub-micromolar concentrations. The reduction of cell survival is caused by a combination of reduced proliferation and induced differentiation of the Neuro2a cells. The complex 7-DHC oxysterol mixture added to control Neuro2a cells also triggers the gene expression changes that were previously identified in Dhcr7-deficient Neuro2a cells. Based on the identification of overlapping gene expression changes in Dhcr7-deficient and 7-DHC oxysterol-treated Neuro2a cells, we hypothesize that some of the pathophysiological findings in the mouse SLOS model and SLOS patients might be due to accumulated 7-DHC oxysterols.

AB - Smith-Lemli-Opitz syndrome (SLOS) is a metabolic and developmental disorder caused by mutations in the gene encoding the enzyme 7-dehydrocholesterol reductase (Dhcr7). This reductase catalyzes the last step in cholesterol biosynthesis, and levels of 7-dehydrocholesterol (7-DHC), the substrate for this enzyme, are elevated in SLOS patients as a result of this defect. Our group has previously shown that 7-DHC is extremely prone to free radical autoxidation, and we identified about a dozen different oxysterols formed from oxidation of 7-DHC. We report here that 7-DHC-derived oxysterols reduce cell viability in a dose-and time-dependent manner, some of the compounds showing activity at sub-micromolar concentrations. The reduction of cell survival is caused by a combination of reduced proliferation and induced differentiation of the Neuro2a cells. The complex 7-DHC oxysterol mixture added to control Neuro2a cells also triggers the gene expression changes that were previously identified in Dhcr7-deficient Neuro2a cells. Based on the identification of overlapping gene expression changes in Dhcr7-deficient and 7-DHC oxysterol-treated Neuro2a cells, we hypothesize that some of the pathophysiological findings in the mouse SLOS model and SLOS patients might be due to accumulated 7-DHC oxysterols.

KW - Free radical oxidation

KW - Gene expression

KW - Lipid peroxidation

UR - http://www.scopus.com/inward/record.url?scp=78149314221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149314221&partnerID=8YFLogxK

U2 - 10.1194/jlr.M009365

DO - 10.1194/jlr.M009365

M3 - Article

C2 - 20702862

AN - SCOPUS:78149314221

VL - 51

SP - 3259

EP - 3269

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 11

ER -